noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Healthcare

Eli Lilly and Company

07/02/2024 | Press release | Distributed by Public on 07/02/2024 11:46

Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | Eli Lilly and Company | News | Health | Science | Research | Local News | Company News | Top Company News | Business Announcement | Products and Services | Pharmaceuticals | Securities Issuers | Pharmaceutical Companies | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Frankfurt Stock Exchange | Six Swiss Exchange | Sao Paulo Stock Exchange (B3) | Vienna Stock Exchange (ATX) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Hamburg Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Bolsa Mexicana de Valores (BMV) | Buenos Aires Stock Exchange (BCBA) | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Cboe BZX Exchange | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | EuroTLX | Proveedor Integral de Precios (PIP) | Bolsa Institucional de Valores (BIVA) | Hannover Stock Exchange | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago | Turquoise

Back

Download the original document